E Tortoli
Overview
Explore the profile of E Tortoli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
1106
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Monteserin J, Paul R, Lopez B, Cnockaert M, Tortoli E, Menendez C, et al.
Int J Tuberc Lung Dis
. 2016 Aug;
20(9):1257-62.
PMID: 27510255
Setting: Over 150 potentially pathogenic non-tuberculous mycobacteria (NTM) species have been described, posing an onerous challenge for clinical laboratory diagnosis. Objective: To evaluate different approaches for the identification of 40...
2.
Dominguez J, Boettger E, Cirillo D, Cobelens F, Eisenach K, Gagneux S, et al.
Int J Tuberc Lung Dis
. 2015 Dec;
20(1):24-42.
PMID: 26688526
The emergence of drug-resistant strains of Mycobacterium tuberculosis is a challenge to global tuberculosis (TB) control. Although culture-based methods have been regarded as the gold standard for drug susceptibility testing...
3.
Chiappini E, Lo Vecchio A, Garazzino S, Marseglia G, Bernardi F, Castagnola E, et al.
Eur J Clin Microbiol Infect Dis
. 2015 Oct;
35(1):1-18.
PMID: 26476550
Tuberculosis (TB) is still the world's second most frequent cause of death due to infectious diseases after HIV infection, and this has aroused greater interest in identifying and managing exposed...
4.
Cambau E, Viveiros M, Machado D, Raskine L, Ritter C, Tortoli E, et al.
J Antimicrob Chemother
. 2015 Jan;
70(3):686-96.
PMID: 25587993
Objectives: Treatment outcome of MDR-TB is critically dependent on the proper use of second-line drugs as per the result of in vitro drug susceptibility testing (DST). We aimed to establish...
5.
DAncona F, Kanitz E, Marinelli L, Sinagra J, Prignano G, Cerocchi C, et al.
Ann Ig
. 2014 Jul;
26(4):305-10.
PMID: 25001120
During the school years 2009-2010 and 2010-2011 a total of 25 cases of Non Tuberculous Cutaneous Mycobacteriosis (NTCM) were notified in children attending the same school with a swimming pool...
6.
van Ingen J, Hoefsloot W, Buijtels P, Tortoli E, Supply P, Dekhuijzen P, et al.
J Med Microbiol
. 2012 Jun;
61(Pt 9):1234-1239.
PMID: 22700551
In this study, nonchromogenic mycobacteria were isolated from pulmonary samples of three patients in the Netherlands. All isolates had identical, unique 16S rRNA gene and 16S-23S ITS sequences, which were...
7.
Piseddu E, Trotta M, Tortoli E, Avanzi M, Tasca S, Solano-Gallego L
J Comp Pathol
. 2010 Oct;
144(2-3):214-8.
PMID: 20880545
Mycobacterium celatum is a slow growing non-tuberculous mycobacterium described mainly as occurring in human patients. Only two cases of infection with this pathogen have been reported previously in animals. A...
8.
Garzelli C, Lari N, Cuccu B, Tortoli E, Rindi L
Clin Microbiol Infect
. 2010 Jan;
16(11):1691-7.
PMID: 20041892
The effects that immigration might have on the epidemiology of tuberculosis (TB) in a low-incidence area of Italy was investigated by determining, in autochthonous and immigrant TB patients, the molecular...
9.
Tortoli E
Clin Microbiol Infect
. 2009 Oct;
15(10):906-10.
PMID: 19845702
The isolation of nontuberculous mycobacteria (NTM) from clinical specimens has become very frequent in the last years. Such organisms are typically environmental and poorly pathogenic for humans; they can, however,...
10.
Tortoli E, Rogasi P, Fantoni E, Beltrami C, De Francisci A, Mariottini A
Clin Microbiol Infect
. 2009 Oct;
16(8):1130-4.
PMID: 19832722
The treatment of multidrug-resistant tuberculosis (TB) requires the use, for long periods, of drugs liable to cause significant side effects. In the case of misdiagnosis of multidrug-resistant TB, the patient...